Unsuccessful transjugular intrahepatic portosystemic shunt for a patient with right heart failure and portal hypertension

被引:0
作者
Graus, L. B. S. [1 ]
Verresen, L. [2 ]
De Vusser, P. [3 ]
Verbrugge, F. H. [3 ]
Caenepeel, P. [4 ]
机构
[1] Katholieke Univ Leuven, Fac Med, B-3000 Leuven, Belgium
[2] Ziekenhuis Oost Limburg, Dept Nephrol, B-3600 Genk, Belgium
[3] Ziekenhuis Oost Limburg, Dept Cardiol, Schiepse Bos 6, B-3600 Genk, Belgium
[4] Ziekenhuis Oost Limburg, Dept Gastroenterol, B-3600 Genk, Belgium
关键词
right heart failure; cardiac cirrhosis; portal hypertension; transjugular intrahepatic portosystemic shunt; LIVER DYSFUNCTION;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A 60-year-old women with a history of congenital pulmonary valve stenosis developed right heart failure, cardiac cirrhosis and end-stage renal disease requiring renal replacement therapy. Cirrhosis was complicated by portal hypertension, resulting in intractable gastro-intestinal bleedings despite optimal treatment with beta-blockers and endoscopic band ligation. Because of fears for worsening right heart failure, a decision for placement of a transjugular intrahepatic portosystemic shunt (TIPS) was initially turned down. However, as intractable bleeding problems persisted and caused heavy transfusion needs, TIPS was ultimately performed as a rescue procedure. Although TIPS successfully reduced the hepatic venous pressure gradient from 16 mmHg to 4 mmHg, portal pressure remained high at 14 mmHg because of persisting right heart failure with elevated central venous pressure. Hepatic encephalopathy soon developed after TIPS placement and culminated in multi-organ failure after another episode of gastro-intestinal bleeding. At this point, the family of the patient decided to withdraw care and the patient died subsequently. This case illustrates how important it is to diagnose and optimally treat right heart failure before cardiac cirrhosis with its impending complications emerges. Although TIPS may effectively treat complications of portal hypertension in the context of cirrhosis, persisting right heart failure may abrogate its beneficial effects.
引用
收藏
页码:63 / 66
页数:4
相关论文
共 12 条
[1]   Liver Abnormalities in Cardiac Diseases and Heart Failure [J].
Alvarez, Alicia M. ;
Mukherjee, Debabrata .
INTERNATIONAL JOURNAL OF ANGIOLOGY, 2011, 20 (03) :135-142
[2]  
Angermayr B, 2011, ACTA GASTRO-ENT BELG, V74, P553
[3]   Current Concepts: Management of Varices and Variceal Hemorrhage in Cirrhosis. [J].
Garcia-Tsao, Guadalupe ;
Bosch, Jaime .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (09) :823-832
[4]   Portal hypertension: from pathophysiology to clinical practice [J].
Laleman, W ;
Van Landeghem, L ;
Wilmer, A ;
Fevery, J ;
Nevens, F .
LIVER INTERNATIONAL, 2005, 25 (06) :1079-1090
[5]   Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation [J].
Lau, GT ;
Tan, HC ;
Kritharides, L .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (12) :1405-+
[6]  
Lo G.-H., 2014, J CHIN MED ASSOC, P1
[7]   Hepatic Hydrothorax [J].
Norvell, John Paul ;
Spivey, James R. .
CLINICS IN LIVER DISEASE, 2014, 18 (02) :439-+
[8]   EFFECTS OF PRAZOSIN AND PHENOXYBENZAMINE ON ALPHA-RECEPTOR AND BETA-RECEPTOR-MEDIATED RESPONSES IN INTESTINAL RESISTANCE AND CAPACITANCE VESSELS [J].
PATEL, P ;
BOSE, D ;
GREENWAY, C .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1981, 3 (05) :1050-1059
[9]   Liver dysfunction in chronic heart failure: prevalence, characteristics and prognostic significance [J].
Poelzl, Gerhard ;
Ess, Michael ;
Mussner-Seeber, Christine ;
Pachinger, Otmar ;
Frick, Matthias ;
Ulmer, Hanno .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (02) :153-163
[10]  
SHIFFMAN ML, 1995, HEPATOLOGY, V22, P1591, DOI 10.1016/0270-9139(95)90169-8